Introduction: Over the past decades, proteins have emerged as versatile carriers for the
diagnosis and treatment of cancer, diabetes, rheumatoid arthritis, and many more diseases …

Introduction: Proteins and peptides are prominent therapeutic agents, which are effective in
number of ailments. Long-term delivery of protein and peptide therapeutics requires …

Nanotechnology platforms, such as nanoparticles, liposomes, dendrimers, and micelles
have been studied extensively for various drug deliveries, to treat or prevent diseases by …

Protein-based nanocarriers have gained considerable attention as colloidal carrier systems
for the delivery of anticancer drugs. Protein nanocarriers possess various advantages …

Nanoscale drug carriers are useful in improving the bioavilability, targeting delivery, and
controlling the release of the loaded drug. Polymers from natural sources possess …

Medicine formulations at the nanoscale, referred to as nanomedicines, have managed to
overcome key challenges encountered during the development of new medical treatments …

Among the available potential colloidal drug carrier systems, protein-based nanocarriers are
particularly interesting. Meeting requirements such as low cytotoxicity, abundant renewable …

Nanoparticles have tremendous potential as a drug delivery system. These substances were
able to attract the attention of scientists by overcoming the problems of gene and drug …

Over the past decade, more interests have been aroused in engineering protein-based
nanoformulations for cancer treatment. This excitement originates from the success of FDA …

Engineered nanoparticles that can facilitate drug formulation and passively target tumours
have been under extensive research in recent years. These successes have driven a new …